The results from MCF7 and MDA-MB-231 cells argues for Ago2 downregulation as a mechanism to lower the effectiveness of the miRNA machinery in aggressive breast cancer cells resulting in increased STIM1 expression to support cell migration. Here, AGO2 is linked to breast carcinoma.